QSAM Biosciences, Inc.
A408WA
Recommendation
--
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
--
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
--
12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 210.43% | 14.60% | -54.23% | 277.90% | -74.95% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 8.16% | -12.62% | -24.22% | -30.94% | 110.42% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 179.40% | 31.93% | -64.15% | 253.89% | -62.23% |
|
|||||
Total Current Assets | 179.40% | 31.93% | -64.15% | 253.89% | -62.23% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 179.40% | 31.93% | -64.15% | 253.89% | -62.23% |
|
|||||
Total Accounts Payable | -52.59% | 38.97% | 0.23% | 15.54% | -24.48% |
Total Accrued Expenses | -98.50% | -32.55% | 47.24% | 9.85% | -90.62% |
Short-term Debt | 0.00% | 0.00% | 0.00% | 0.00% | -98.68% |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | 9.10% | 10.01% | 11.00% | 12.21% | 14.29% |
Total Other Current Liabilities | 9.10% | 10.01% | 11.00% | 12.21% | 14.29% |
Total Current Liabilities | -39.61% | 24.13% | 6.22% | -17.90% | -40.71% |
|
|||||
Total Current Liabilities | -39.61% | 24.13% | 6.22% | -17.90% | -40.71% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 0.00% | 0.00% | 0.00% | 0.00% | -98.68% |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | -39.61% | 24.13% | 6.22% | -17.90% | -40.71% |
|
|||||
Common Stock & APIC | 6.23% | 2.47% | 4.78% | 9.29% | 5.91% |
Retained Earnings | -1.22% | -3.13% | -3.32% | -5.84% | -4.61% |
Treasury Stock & Other | 3.29% | 4.70% | -4,012.39% | 81.05% | 46.26% |
Total Common Equity | 108.85% | -11.63% | -124.52% | 62.03% | 19.76% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -31.45% | 0.98% | 0.99% | 1.00% | 1.01% |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -31.45% | 0.98% | 0.99% | 1.00% | 1.01% |
|
|||||
Total Common Equity | 108.85% | -11.63% | -124.52% | 62.03% | 19.76% |
Total Preferred Equity | -31.45% | 0.98% | 0.99% | 1.00% | 1.01% |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 161.11% | -20.19% | -13,165.22% | 99.43% | 28.48% |
|